Pulse Biosciences Inc (6L8)
XDUS
42.80
-0.40 (-0.93%)
Real-time Data
06:00 AM
Day's Range
42.8043.40
52 wk Range
10.9049.00
Financial Statements - 6L8 - Pulse Biosciences Inc
Revenue
350.00K
Net Income
-72.78M▼ 60.3%Net Margin -20794.6%
EBITDA
-75.86M▼ 62.6%
Free Cash Flow
-54.45M▼ 76.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 350K | 0 |
| Cost of Goods | 539K | - |
| Gross Profit | -189K | - |
 Operating Expense | - | - |
| Operating Income | -76.93M | -47.65M |
| Non-Operating Interest | - | - |
| Other Income Expense | -52K | - |
| Pre Tax Income | -72.78M | -45.38M |
| Income Tax | - | 0 |
| Net Income | -72.78M | -45.38M |
| EPS Basic | -1.08 | -0.92 |
| EPS Diluted | -1.08 | -0.92 |
| Basic Shares Outstanding | 67.39M | 49.46M |
| Diluted Shares Outstanding | 67.39M | 49.46M |
| Ebit | -76.93M | -47.65M |
| Ebitda | -75.86M | -46.65M |
| Net Income Continuous Operations | -72.78M | -45.38M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
